Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
PatientBase is the premier epidemiology database that provides robust coverage of more than 120 disease indications and more than 2000 patient populations... Learn More
Join us live on June 4, 2013... Learn More
View Webinar schedule and archive
See which reports have been searched on the most.
Deal Trends Show Creativity, Back-end Loaded Rewards, and a Focus in New Markets
This Pharmaview white paper analyzes deal activities among the major companies in the pharmaceutical industry, focusing on transactions that occurred between January 2009 and October 2012. This analysis highlights the most active deal-makers in each of the major geographic regions – the U.S., Europe and Japan.
May 21, 2013
Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
May 20, 2013
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
May 14, 2013
In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
Hepatitis C Virus in Turkey
The Turkish government has heavily invested in healthcare
over the past two decades, which results in sustained growth... Read More
Neuropathic Pain: U.S. Payer and Prescriber Attitudes Toward Recently Approved and Emerging Therapies—Implications for Market Access
Neuropathic pain (NP) is a prominent form of pain associated
with a variety of diseases and conditions, including... Read More
Global: Market Access Tracker
Last Updated 22 May 2013Decision Resources’ Market
Access Tracker service explains the challenges... Read More